A prokaryotic expression plasmid, pKK-DT2, containing the cDNA of rat liver NAD(P)H: quinone-acceptor oxidoreductase (EC 1.6.99.2; DT-diaphorase) was constructed and used to transform Escherichia coli strain JM 109. The rat liver quinone reductase was expressed in strain in JM109 and was inducible with isopropyl /J-D-thiogalactopyranoside (IPTG). The expressed rat protein was purified by affinity chromatography and had kinetic and physical properties identical with the protein purified from rat liver in that it could utilize either NADH or NADPH as the electron donor and its activity was inhibited by dicoumarol. In addition, we have generated four mutants, Arg-177 -+ His (R177H), Arg-177 -+ Ala (R177A), Arg-177 -+ Cys (R177C) and Arg-177 -+ Leu (R177L), using this expression system. Several of the mutants behaved anomalously on SDS/PAGE, but all of the mutant proteins had the expected Mr as determined by electrospray m.s. These results and those obtained from enzyme kinetic analysis, u.v./visible absorption spectral analysis, and flavin and tryptophan fluorescence analysis of the wild-type enzyme and four mutants indicated that mutations at Arg-177 changed the conformation of the enzyme, resulting in a decrease in enzyme activity. Replacing Arg-177 with leucine altered the protein conformation and decreased FAD incorporation.
INTRODUCTION
NAD(P)H: quinone-acceptor oxidoreductase (EC 1.6.99.2; DT-diaphorase) plays an important role in protecting tissues against the mutagenic, carcinogenic and cytotoxic effects of quinones which occur widely in nature (Ernster, 1987) . Protection is accomplished by the unique ability of this quinone reductase to catalyse an obligatory two-electron reduction of several quinones, including vitamin K (e.g. menadione), to hydroquinones with either NADH or NADPH as electron donor (lyanagi & Yamazaki, 1970; lyanagi, 1987) . This reaction is thought to bypass the semiquinone free-radical state, diminishing the formation of quinone-mediated oxygen free radicals which are generated by redox cycling of semiquinones in the presence of oxygen.
The primary structure of rat liver NAD(P)H: quinone-acceptor reductase has been deduced from cDNA sequences (Robertson et al., 1986; Bayney et al., 1987) and determined by protein microsequencing methods (Haniu et al., 1988) . The amino acid sequence of the human enzyme has also been deduced from the cDNA sequence (Jaiswal et al., 1988) . This enzyme consists of two identical subunits. Each subunit contains 273 residues and one molecule of the FAD prosthetic group (Hosoda et al., 1974; Rase et al., 1976) . Although the primary structure of this quinone reductase has been determined independently by different groups during the last several years, the structure-function relationship remains unidentified.
Previous studies of the rat liver enzyme using affinity-labelling experiments with 5'-fluorosulphonylbenzoyladenosine (5'-FSBA) revealed a region of this enzyme, 146I-T-T-G-G-S-G-S-M-Y155, that is thought to be a part of the nicotinamide nucleotidebinding site (Liu et al., 1989) . Forrest et al. (1990) expressed the rat liver enzyme in COS7 cells and initiated site-directed mutagenesis experiments near the proposed nicotinamide nucleotidebinding site. In order to characterize further the structurefunction relationship of NAD(P)H: quinone oxidoreductase, we have recently constructed an expression plasmid and succeeded in expressing the rat liver enzyme in Escherichia coli. The expressed enzyme has been purified and characterized. Using this expression system, four mutants, Arg-1 77 -+ His (Rl 77H), Ala (R177A), Arg-177 -+Cys (R177C) and Leu (R177L), were produced and their properties examined. EXPERIMENTAL Rat liver NAD(P)H:quinone-acceptor oxidoreductase expression in E. coli A Ncol /HindIII fragment containing the coding region for rat liver NAD(P)H:quinone-acceptor oxidoreductase was isolated from the pCMV-DT plasmid constructed previously (Forrest et al., 1990) . This cDNA fragment was ligated into Ncol and Hindlll-restricted prokaryotic expression vector pKK233.2 (Pharmacia, Piscataway, NJ, U.S.A.). The resulting expression plasmid, pKK-DT2, was used to express rat quinone reductase in E. coli strain JM 109 (Fig. 1) .
The conditions for expressing this quinone reductase in E. coli are as follows. The expression plasmid pKK-DT2 was transformed into the JM109 strain. 2X YT (2 ml; 1 1 of 2X YT contains 16 g of bactotryptone, 10 g of yeast extract and 10 g of NaCl, pH 7.5) containing ampicillin (75 ,tg/ml) was inoculated with a single colony of the JM109-pKK-DT2 transformant. After an overnight incubation at 37°C, the 2 ml culture was used to inoculate 50 ml of prewarmed 2X YT. When the A600 of the E. coli culture reached 0.6, isopropyl /J-D-thiogalactopyranoside (IPTG) was added to a final concentration of 2 mm to induce expression of the quinone reductase. Portions (5 ml) were withdrawn at different time intervals, and quinone reductase activity was determined. For measurement of quinone reductase activity, cells were centrifuged for 15 min at 5000 g, transferred to an Eppendorf tube, washed with 1 ml of phosphate-buffered saline (PBS; contains 8 g of NaCl, 0.24 g of KCI, 1.44 g of Na2HPO4 and 0.24 g of KH2PO,) (Sambrook et al., 1989) followed by one wash in buffer A (50 mM-Tris buffer, pH 7.5, and 100 mM-NaCl).
Vol. 284
Abbreviations used: 5'FSBA, 5'-fluorosulphonylbenzoyladenosine; IPTG, isopropyl f-D-thiogalactopyranoside; PBS, phosphate-buffered saline;
TFA, trifluoroacetic acid.
t To whom correspondence should be addressed. cycle with output-control setting at 4). The sonicated cell mixtures were centrifuged at 13600 g for 10 min. The supernatant was measured for quinone reductase activity.
Purification of the expressed quinone reductase Transformed JM109 cultures (2 litres) were grown for 17 h in the presence of 2 mM-IPTG, and harvested as described in the previous section. The cells were washed with 200 ml of PBS, followed by 200 ml of buffer A, and resuspended in 60 ml of buffer A. After sonication (3 x 20 s at 400% duty cycle with output-control setting at 4), the cell debris was removed by centrifugation at 10000 rev./min (13800g) for 10min in a Beckman JA-17 rotor. The pellets were resuspended in 60 ml of buffer A and sonicated again. The supernatants were combined and centrifuged at 40000 rev./min (105000 g) for 90 min in a Beckman 50.2Ti rotor. The supernatant from this centrifugation was applied to a 50 ml Affi-gel Blue (Bio-Rad) column (2.5 cm x 10 cm) which was equilibrated with 500 ml of buffer A. The elution procedure was basically in accordance with the method described by Prochaska (1988) . However, 50 % ethylene glycol was omitted from the final elution buffer, and the enzyme was not released from the Affi-gel Blue resin by washing with 20 mM-Tris buffer, pH 10, containing 1 mM-NADH. Therefore the column was washed with 3 bed vol. of 50 mM-Tris buffer (pH 7.5)/0.25 M-sucrose/0.5 M-KCI, which was used in the method described by Sharkis & Swenson (1989) . The enzyme was eluted from the column with the latter buffer containing 8 mm-NADH. The active fractions were pooled and concentrated by precipitation with 75 % satd. (NH4)2SO4. The enzyme pellet was resuspended in a small volume of 50 mM-potassium phosphate, pH 7.5, and dialysed against the same buffer. The purified enzyme was stored at -70°C.
Enzyme assay NAD(P)H :quinone-acceptor oxidoreductase activity was determined spectrophotometrically be measuring the reduction of cytochrome c at 550 nm (e550 = 18.5 x 103 M-1 * cm-') at 25 'C. Unless indicated specifically, the routine assay mixture (1 ml) contained 25 mM-Tris buffer, pH 7.5, 200 #M-NAD(P)H, 0.8 ,uMmenadione and 30 ,sM-cytochrome c. In this assay, menadione is the electron acceptor, and cytochrome c is used to reoxidize the menadiol formed. The reaction was initiated by addition of the enzyme. The assays were performed at least in duplicate. When assays were performed on a crude enzyme preparation, the activity of the expressed quinone reductase was distinguished from those of other quinone reductases by its sensitivity to treatment with 1 ,tM-dicoumarol, which completely inhibits it (Ernster et al., 1962) . Protein concentrations were determined by the method of Bradford (1976) .
Site-directed mutagenesis experiments
The Altered Sites Mutagenesis Kit from Promega Co. (Madison, WI, U.S.A.) was used for the mutagenesis experiments. A HindIII cDNA fragment (1286 bp) containing the coding and 3'-flanking regions of the rat liver quinone reductase was excised from the pCMV-DT plasmid (Forrest et al., 1990) and subcloned into the pSelect-1 plasmid (Promega) . On transformation into the JM 109 strain, single-stranded DNA was generated by infecting with helper phage R408. Site-directed mutagenesis at Arg-177 was accomplished by annealing the singlestranded DNA with an ampicillin repair oligonucleotide (Promega) and with mixed synthetic primers, 5'-GAAGCCACAGAANNNCAGAATGCCACT-3'. The second strand was synthesized with T4 DNA polymerase and ligated with T4 DNA ligase. The products were transformed into E. coli BMH 71-18 MutS strain (a mismatch repair minus strain; Promega). The DNA prepared from ampicillin-resistant overnight culture was then transformed into the JM 109 strain and plated on Luria broth plates containing 125 ,ug of ampicillin/ml.
The mutants were further identified by the disappearance of a Hha restriction site (GCGC) within the mutated region, CTGLl76CGCRl77TTCFl78. The specific mutants were then identified by direct DNA sequencing. All mutant cDNA fragments were sequenced completely to confirm that there were no other mutations except those designed. The NcoI/HindIII fragment was excised from each mutant and subcloned into the expression vector, pKK233.2, as described for the construction of the pKK-DT2 plasmid.
Five mutants were generated by the method described above. They were R177H, R177A, R177C, R177L and R177P.
SDS/PAGE
Purified quinone reductase and its mutants were analysed by SDS/PAGE by the method of Laemmli (1970 
Spectral analyses
The purified enzymes were dialysed extensively z phosphate buffer, pH 7.5, at 4°C to remove NAI used to elute the enzyme from the Affi-gel Blue a] The u.v./visible spectra of the wild-type and mu were recorded using a Hitachi U-31 10 spectrop Shimadzu RF5000 spectrofluorophotometer was escence analysis. The FAD fluorescence of the pu was quenched and could be detected only un( conditions. Tryptophan emission spectra of these generated by setting the excitation wavelength 295 nm.
RESULTS
Expression of rat liver NAD(P)H:quinone-accepto oxidoreductase in E. coli
As shown in Fig. 2 , the expression of the quinor E. coli strain JM109 transformed with the expre FSBA identified a region, 461I-T-G-G-S-G-S-M-Y'55, which was tentatively assigned as part of the nicotinamide nucleotidebinding site (Liu et al., 1989) . On the basis of this and secondarystructure analysis of the amino acid sequence (Forrest et al., 1990) , it was concluded that this segment of the protein might be near the region where the pyrophosphate group of the NAD(P)H molecule binds. This enzyme has an unusual nicotinamide nucleotide-binding site in that it utilizes either NADH or NADPH as electron donor with equal maximal velocities (Ernster et al., 1962) . This indicates that the nicotinamide nucleotide-binding site of the enzyme has a structure that can accommodate either NADH or NADPH. The structural difference between NADH and NADPH is the presence of a phosphate group at the 2' position of the ribose of the AMP portion of NADPH. Basic amino acid residues, such as arginine, lysine and histidine, are often found to form hydrogen bonds with the 2'-phosphate group of NADP(H) (e.g. Pai et al., 1988; Scrutton et al., 1990; Bystroff et al., 1990 In order to test the hypothesis described above, mutations were generated at Arg-177 using a cassette mutagenesis approach: mutants R177H, R177A, R177C, R177L and R177P were generated. Mutant R177P had no enzyme activity and was not studied further. Mutant RI 77H was purified in a manner identical from a 2-litre with that for the wild-type enzyme. Mutants RI 77A, RI 77C and R177L were eluted from the affinity column with a 1-5 mm-NADH gradient in 20 mM-Tris buffer, pH 10.
The purity of E. coli-expressed NAD(P)H:quinone-acceptor oxidoreductase and the mutant preparations was analysed by ification Yield SDS/PAGE. All of the mutant enzymes except R177L displayed 'fold) (%) a single band on SDS/polyacrylamide gels (Fig. 3) (Fenn et al., 1989 , RI 77L. Inset, FAD fluorescence spectra for the wildtype enzyme and its mutants. The protein concentration of the enzyme solutions was 0. I mg/ml. the concentration of fixed substrate were made, and the true Km and V.ax. values for NAD(P)H and menadione were derived from these secondary plots. The V..ax values for the wild-type enzyme were determined to be 7670,umol/min per mg when NADH was used as the electron donor and 5000 ,umol/min per mg when NADPH was used as the electron donor. The Km values for NADH and NADPH for the wild-type enzyme were 36.2 and 9.5 /tM respectively. The Km values for menadione (with NADH or NADPH as the electron donor) were 1.38 and 0.48 JuM respectively.
The Km values for NAD(P)H and menadione for four mutants were very similar to those of the wild-type enzyme, except that the Km value of NADH for R177A was slightly lower (i.e. 26.7 /M), that of NADPH for R177H was slightly higher (i.e. 21.9,UM) and that of menadione (when using NADH as the electron donor) for RI 77A was slightly lower (i.e. 0.83 /IM) than those of the wild-type enzyme. In contrast with small differences in Km values, R177H had 30-40%, R177A and R177C had 15-25% and R177L had 2-4% of the wild-type activity. The dicoumarol-inhibition profiles for the wild-type and four mutants were essentially the same. More than 500% inhibition of the enzyme and its mutants was obtained with 10 nM-dicoumarol. Enzyme activity was completely inhibited in the presence of 200 nM-dicoumarol. NAD(P)H: quinone-acceptor oxidoreductase contains FAD as the prosthetic group. The wild-type quinone reductase, along with mutants R177H, R177A and R177C, displayed typical u.v./visible absorption spectra for flavoproteins (Fig. 4) . Mutant R177C contained slightly less FAD than the wild-type enzyme, whereas mutants R177H and R177A contained normal amounts of FAD based on this u.v./visible absorption spectral analysis. Mutant R177L had an unusual absorption spectrum in that typical flavin absorption peaks were not seen (Fig. 4) Fig. 4) . On the basis of this FAD fluorescence analysis, the protein concentration of mutant R177H was slightly higher than the estimated concentration. The flavin fluorescence is quenched completely for non-denatured enzyme.
DISCUSSION
This paper describes the construction of an expression plasmid, pKK-DT2, and the expression of rat liver NAD(P)H: quinoneacceptor oxidoreductase in E. coli. The expression of quinone reductase is IPTG-inducible and is different from the plasmid developed by Ma et al. (1990) . By using this expression system, approx. 50 mg of the enzyme can be purified from an overnight 3-litre culture. The N-terminus of the expressed enzyme is not blocked. Haniu et al. (1988) (Fig. 4) . In addition, three other mutants have similar flavin content, but they have only 20-30-% of the activity of the wild-type enzyme. Therefore, mutations at position 177 brought additional change(s) which affect the enzyme activity. It was recently found that tryptophan fluorescence of mutants R177H, R177A and R177C was more intense than that of the wild-type enzyme (results not shown). In addition, there was a blue shift of emission maximum for the tryptophan fluorescence of mutant R177L. The changes in tryptophan fluorescence of the mutants suggested significant conformational change in the protein on mutagenesis. The perturbation of the mutant conformation may alter the migration of mutants on SDS/ polyacrylamide gel as discussed above. Arg-177 may be important in forming hydrogen bonds with acidic residue(s) to maintain the correct protein conformation. The blue shift of the tryptophan fluorescence for R177L suggests that the introduction of a leucine residue at position 177 places the affected tryptophan residue(s) in a more hydrophobic environment.
To summarize our results, although Arg-177 of rat liver NAD(P)H: quinone-acceptor oxidoreductase seems not to play a role in nicotinamide nucleotide or quinone binding, this residue may be important in maintaining the structure of this enzyme for proper catalysis. A mutation at position 177 of this enzyme causes protein conformational changes which affect its catalysis. For mutant R177L, the protein conformation is perturbed to such an extent that FAD incorporation is also significantly affected.
NAD(P)H: quinone-acceptor oxidoreductase is an unusual nicotinamide nucleotide-dependent quinone reductase because it can utilize either NADH or NADPH as the electron donor. As indicated in the Results section, it is difficult to design mutants of this quinone reductase to distinguish the nicotinamide nucleotide selectivity without information on its X-ray structure, particularly when the amino acid sequence is distinctly different from that of other nicotinamide nucleotide-dependent enzymes. We have designed mutants relying on information generated from affinity-and photoaffinity-labelling experiments. The success in expressing the enzyme in E. coli and purifying the mutant proteins in significant quantities will allow the characterization of these proteins in a more detailed manner. These analyses are important to enable evaluation of our initially stated hypothesis.
